Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect

Micelle-contained and PEGylated hybrid liposomes of combined gemcitabine and cisplatin delivery for enhancing antitumor activity

(2021) Zixu Liu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Improving plasma stability and antitumor effect of gemcitabine via PEGylated liposome prepared by active drug loading

(2020) Ning Ding et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy

(2020) Ting-Yu Chen et al.   Pharmaceutics

Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance

(2019) Qiuyue Chen et al.   Acta Biomaterialia

Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery

(2019) Yinwen Li et al.   ACS Applied Materials & Interfaces

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

(2019) Rui-Mei Feng et al.   Cancer Communications

Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells

(2019) Alejandra Gonzalez-Urias et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer

(2019) Yaping Wang et al.   CARBOHYDRATE POLYMERS

Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling

(2019) Courtney Sakolish et al.   TOXICOLOGY IN VITRO

A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity

(2018) Yueyang Qu et al.   BIOMATERIALS

Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics

(2018) Kathleen A. Cronin et al.   CANCER

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting

(2018) Minglu Zhou et al.   Acta Pharmaceutica Sinica B

Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment

(2017) Yu-Guo Yuan et al.   International Journal of Nanomedicine

Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complex

(2017) Chander Parkash Dora et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer

(2017) Rongrong Zhang et al.   Drug Design Development and Therapy

Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles

(2017) Liang Zou et al.   Oncotarget

Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer

(2016) Sonja Schelhaas et al.   CANCER RESEARCH

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

(2016) Timothy C. Johnstone et al.   CHEMICAL REVIEWS

Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug

(2016) Maryam Parsian et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Novel Improved Synthesis of HSP70 Inhibitor, Pifithrin-μ. In Vitro Synergy Quantification of Pifithrin-μ Combined with Pt Drugs in Prostate and Colorectal Cancer Cells

(2016) Aoife McKeon et al.   MOLECULES

Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter

(2015) John C. Ashton   CANCER RESEARCH

HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

(2015) Rosa Sottile et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan–thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers

(2015) Zeynep Ay Şenyiğit et al.   International Journal of Nanomedicine

Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer

(2014) Lei Miao et al.   ADVANCED FUNCTIONAL MATERIALS

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer

(2014) Shixian Lv et al.   BIOMATERIALS

Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin

(2014) Mingqiang Li et al.   BIOMATERIALS

Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

(2014) Lucas de Sousa Cavalcante et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation

(2014) Qian Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanoscaled Poly(l-glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer

(2013) Mingqiang Li et al.   ACS Applied Materials & Interfaces

Potential Use of Drug Loaded Nano Composite Pectin Scaffolds for the Treatment of Ovarian Cancer

(2013) Sarika Chandran et al.   Current Drug Delivery

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

(2011) Brian R. Sloat et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH